James Arthur Bristol
CIK 1715153 · last filed 2026-01-05
James Arthur Bristol is a corporate insider who has filed 32 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for ERAS, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$9.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.92M
3
32
-$9.01M
Holdings By Company
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2025-02-10 | ERNA | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-04-29 | ERNA | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Grant (A) | — | $0 | EDGAR |